Bluetongue

2 minutes read

Bluetongue is a vector A carrier of a disease-causing agent from an infected individual to a non-infected individual or its food or environment; for example, mosquitoes carrying malaria parasites.-borne viral disease of domestic and wild ruminants such as sheep, goats, cattle and deer.

It is transmitted through the bites of certain species A subdivision of the genus, a species is a group of closely related and similar-looking organisms; for example, in the case of Homo sapiens (humans), the second part of the name (sapiens) represents the species. of Culicoides midges. Currently there are 26 known serotypes of the virus, with different rates of virulence The degree or ability of a disease-causing organism (e.g. a bacterium, virus or parasite) to cause disease. and mortality.

Bluetongue does not affect humans, but it can cause considerable damage to livestock populations. It is a transboundary disease, so national measures are insufficient to control its spread.

Milestones

2017
March
Experts review control measures for bluetongue and options for safe trade of animals from infected to free areas. They also update their scientific advice on epidemiological aspects of the disease, particularly its transmission patterns.
2011
June
A scientific opinion estimates the prevalence of the disease under different circumstances and the appropriate size of geographical areas for monitoring.
2008
November
Experts assess the risk of transmission of the virus when animals are in transit through infected areas. The risk cannot be quantified due to a lack of data, but experts find that treating animals with insecticides or repellents may help to reduce the risk.
July
EFSA delivers advice on bluetongue with specific reference to the overwintering of the bluetongue virus and the measures that can be used to protect animals against attacks by vectors. Although no single mechanism is responsible for the survival of the bluetongue virus over winter, experts conclude that infected midges are the likeliest explanation.
2007
EFSA provides weekly reports on the disease situation and an epidemiological analysis of the outbreak.
April
The report of the global epidemiological analysis of the north-western European outbreak is published. It covers the origin, clinical signs, and spread of the disease.
2006
September
Shortly after a Bluetongue outbreak in Northern Europe, EFSA asks Member States to share national risk assessments and information they have on the disease.

EFSA's role

EFSA provides scientific support on Bluetongue to the European Commission, European Parliament and EU Member States. Its activities focus on furthering scientific understanding of the dynamics and spreading patterns of the disease in Europe, and on providing a scientific basis for risk management The management of risks which have been identified by risk assessment. It includes the planning, implementation and evaluation of any resulting actions taken to protect consumers, animals and the environment. measures. Examples of aspects investigated:

The epidemiology The study of how often diseases and other health conditions occur in different groups of people and why. It includes the study of health-related measurements (e.g. pesticide exposure or vitamin deficiency) in a population and how they may influence the risk of ill health. and clinical diagnosis of different strains.
The role of insects in spreading the disease.
The means to control the insects that spread Bluetongue, such as insecticides, repellents and other ways of protecting animals from insect bites.
The use of vaccines to reduce the risk of infection.
The risks of disease transmission during animal transport.